ADAPTIMMUNE THERAPEUTICS PLC shareholders Q3 2023

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 78 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

ADAPTIMMUNE THERAPEUTICS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 6,287,101$4,903,9392.63%
Syncona Portfolio Ltd 1,377,294$1,074,2891.60%
MPM BioImpact LLC 5,095,912$3,974,8111.06%
NEA Management Company, LLC 17,079,778$13,322,2271.03%
TANG CAPITAL MANAGEMENT LLC 5,166,954$4,030,2240.57%
PFM Health Sciences, LP 10,423,135$8,130,0450.38%
Matrix Capital Management Company, LP 38,974,185$30,399,8640.36%
Long Focus Capital Management, LLC 10,963,158$8,551,2630.31%
Acuitas Investments, LLC 479,764$374,2160.22%
Endurant Capital Management LP 311,944$243,3160.22%
Key Client Fiduciary Advisors, LLC 316,325$246,7340.15%
DAFNA Capital Management LLC 351,064$273,8300.08%
Rock Springs Capital Management LP 2,787,845$2,174,5190.06%
Baker Brothers Advisors 10,969,282$8,556,0400.05%
Artal Group S.A. 1,133,775$8840.04%
Black Maple Capital Management LP 69,839$54,4740.04%
Redmile Group, LLC 715,607$558,1730.03%
HARBOR CAPITAL ADVISORS, INC. 134,415$104,8440.02%
Marquette Asset Management, LLC 99,349$77,4930.02%
X-Square Capital, LLC 26,771$250.02%
External links

This page lists ADAPTIMMUNE THERAPEUTICS PLC's shareholders in Q3 2023. To view ADAPTIMMUNE THERAPEUTICS PLC's shareholder history, click here.